Literature DB >> 29337089

Thermal Field Distributions of Ablative Experiments Using Cyst-mimicking Phantoms: Comparison of Microwave and Radiofrequency Ablation.

Xiao-Wen Huang1, Fang Nie2, Zeng-Cheng Wa3, Hang-Tong Hu1, Qing-Xiu Huang4, Huan-Ling Guo1, Qiao Zheng1, Xiao-Yan Xie1, Wei Wang5, Ming-De Lu6.   

Abstract

RATIONALE AND
OBJECTIVES: The objective of this study was to explore the thermal field distribution of cystic lesions undergoing microwave ablation (MWA) and radiofrequency ablation (RFA) using in vitro phantoms.
MATERIALS AND METHODS: Cyst-mimicking lesions filled with sodium chloride (NaCl) solution in acrylamide phantoms were treated with MWA and RFA in vitro. The radiofrequency electrodes or MWA antennas were implanted in the centers of the artificial cystic lesions. We used temperature fields located 5, 15, and 25 mm from the electrode or the antenna to plot the temperature-rise curves. Solid phantoms without cysts were also fabricated as controls.
RESULTS: The temperature within cysts increased faster and reached a higher maximum temperature during MWA than during RFA, and this result was independent of the NaCl solution concentration. RFA treatment caused the temperatures within the lesion to increase significantly faster in the cysts containing 0.9% NaCl than in those containing 5.0% NaCl. However, the MWA temperature-rise curves were only weakly affected by the ionic concentration. The median temperature difference values between the 5- and 15-mm points were markedly lower in the 0.9% NaCl cyst-mimicking phantom (P <0.001) than in the solid phantom after either MWA or RFA.
CONCLUSIONS: Our data indicate that MWA is a more effective technique for focal cystic lesions than RFA and has higher overall energy utilization. MWA was also less affected by the ionic concentration of the cystic fluid.
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Microwave ablation; experiment; phantom; radiofrequency ablation

Mesh:

Substances:

Year:  2018        PMID: 29337089     DOI: 10.1016/j.acra.2017.11.010

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  2 in total

1.  Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis.

Authors:  Wei-Yu Yang; Yu He; Qikang Hu; Muyun Peng; Zhe Zhang; Shouzhi Xie; Fenglei Yu
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

2.  How large is the periablational zone after radiofrequency and microwave ablation? Computer-based comparative study of two currently used clinical devices.

Authors:  Macarena Trujillo; Punit Prakash; Pegah Faridi; Aleksandar Radosevic; Sergio Curto; Fernando Burdio; Enrique Berjano
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.